Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Michelle Renee Campbell. (2020) Update on molecular companion diagnostics - a future in personalized medicine beyond Sanger sequencing. Expert Review of Molecular Diagnostics 20:6, pages 637-644.
Read now
Read now
Jennifer Mary Eastel, Ka Wai Lam, Nga Lam Lee, Wing Yan Lok, Andy Hin Fung Tsang, Xiao Meng Pei, Amanda Kit Ching Chan, William Chi Shing Cho & Sze Chuen Cesar Wong. (2019) Application of NanoString technologies in companion diagnostic development. Expert Review of Molecular Diagnostics 19:7, pages 591-598.
Read now
Read now
Yong-Jie Zhou, Guanghua Wang & Yi-Wei Tang. (2018) Companion diagnostics: new opportunities for safe and effective anti-infectious disease therapies. Emerging Microbes & Infections 7:1, pages 1-2.
Read now
Read now
Emma Budd, Giovanna Nalesso & Ali Mobasheri. (2018) Extracellular genomic biomarkers of osteoarthritis. Expert Review of Molecular Diagnostics 18:1, pages 55-74.
Read now
Read now
Samantha A. Byrnes & Bernhard H. Weigl. (2018) Selecting analytical biomarkers for diagnostic applications: a first principles approach. Expert Review of Molecular Diagnostics 18:1, pages 19-26.
Read now
Read now
Giuseppe Pelosi, Aldo Scarpa, Fabien Forest & Angelica Sonzogni. (2016) The impact of immunohistochemistry on the classification of lung tumors. Expert Review of Respiratory Medicine 10:10, pages 1105-1121.
Read now
Read now
Ronald L Van Heertum, Robert Scarimbolo, Robert Ford, Eli Berdougo & Michael O’Neal. (2015) Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials. Drug Design, Development and Therapy 9, pages 5215-5223.
Read now
Read now
Camille C Gunderson & Kathleen N Moore. (2015) BRACAnalysis CDx as a companion diagnostic tool for Lynparza. Expert Review of Molecular Diagnostics 15:9, pages 1111-1116.
Read now
Read now
Articles from other publishers (30)
Evangel SarwarEvangel Sarwar. 2023. Global Perspectives on Precision Medicine. Global Perspectives on Precision Medicine
157
188
.
Daniel Lütkemeyer, H. Sebastian Heese, David A. Wuttke & Andreas K. Gernert. (2022) Pricing and market entry decisions in personalized medicine. International Journal of Production Economics 253, pages 108584.
Crossref
Crossref
Lisa Cooper & Joyce Chen. (2022) Changes in Companion Diagnostic Labelling: Implementation of FDA’s April 2020 Guidance for Industry for In Vitro CDx Labeling for Specific Oncology Therapeutic Groups. Therapeutic Innovation & Regulatory Science 56:5, pages 689-697.
Crossref
Crossref
Hongqin Zhu, Feng Ren, Tingting Wang, Zhilin Jiang, Qiao Sun & Zhen Li. (2022) Targeted Immunoimaging of Tumor‐Associated Macrophages in Orthotopic Glioblastoma by the NIR‐IIb Nanoprobes. Small 18:30, pages 2202201.
Crossref
Crossref
Jorge Manzanares, Francisco Sala, María Salud García Gutiérrez & Francisco Navarrete Rueda. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
693
724
.
Hiroaki Nitta, Mark D. Robida & Nate Polaske. 2022. Handbook of Practical Immunohistochemistry. Handbook of Practical Immunohistochemistry
77
85
.
Tony Jung & Neeraj Vij. (2021) Early Diagnosis and Real-Time Monitoring of Regional Lung Function Changes to Prevent Chronic Obstructive Pulmonary Disease Progression to Severe Emphysema. Journal of Clinical Medicine 10:24, pages 5811.
Crossref
Crossref
Subotheni Thavaneswaran, Mandy Ballinger, Phyllis Butow, Bettina Meiser, David Goldstein, Frank Lin, Christine Napier, David Thomas & Megan Best. (2021) The experiences and needs of Australian medical oncologists in integrating comprehensive genomic profiling into clinical care: a nation-wide survey. Oncotarget 12:21, pages 2169-2176.
Crossref
Crossref
Gustavo A. Arias-Pinilla & Helmout Modjtahedi. (2021) Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities. Cancers 13:8, pages 1781.
Crossref
Crossref
Daniel Lütkemeyer, H. Sebastian Heese & David A. Wuttke. (2021) Overcoming inefficiencies in the development of personalized medicine. European Journal of Operational Research 290:1, pages 278-296.
Crossref
Crossref
Dae Gyu Kim, Thi Thu Ha Nguyen, Nam Hoon Kwon, Junsik Sung, Semi Lim, Eun-Joo Kang, Jihye Lee, Woo Young Seo, Arum Kim, Yoon Soo Chang, Hyunbo Shim & Sunghoon Kim. (2020) An Isoform of the Oncogenic Splice Variant AIMP2-DX2 Detected by a Novel Monoclonal Antibody. Biomolecules 10:6, pages 820.
Crossref
Crossref
Ezzat M. Abdel-Moety, Amal M. Abou Al-Alamein, Esraa Fawaz & Mohamed K. Abd El-Rahman. (2020) A Companion Diagnostic for Personalizing Mivacurium at the Point-of-Care. Journal of The Electrochemical Society 167:8, pages 087510.
Crossref
Crossref
Molly J. Carroll, Carl R. Parent, David Page & Pamela K. Kreeger. (2019) Tumor cell sensitivity to vemurafenib can be predicted from protein expression in a BRAF-V600E basket trial setting. BMC Cancer 19:1.
Crossref
Crossref
Kaustav Bera, Kurt A. Schalper, David L. Rimm, Vamsidhar Velcheti & Anant Madabhushi. (2019) Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology. Nature Reviews Clinical Oncology 16:11, pages 703-715.
Crossref
Crossref
Piero Cappelletti. (2019) Le malattie croniche e la medicina di laboratorio. La Rivista Italiana della Medicina di Laboratorio 15:2.
Crossref
Crossref
Ali K. Yetisen, Rosalia Moreddu, Sarah Seifi, Nan Jiang, Katia Vega, Xingchen Dong, Jie Dong, Haider Butt, Martin Jakobi, Martin Elsner & Alexander W. Koch. (2019) Dermal Tattoo Biosensors for Colorimetric Metabolite Detection. Angewandte Chemie International Edition 58:31, pages 10506-10513.
Crossref
Crossref
Ali K. Yetisen, Rosalia Moreddu, Sarah Seifi, Nan Jiang, Katia Vega, Xingchen Dong, Jie Dong, Haider Butt, Martin Jakobi, Martin Elsner & Alexander W. Koch. (2019) Dermal Tattoo Biosensors for Colorimetric Metabolite Detection. Angewandte Chemie 131:31, pages 10616-10623.
Crossref
Crossref
Suso Platero. 2019. Handbook of Biomarkers and Precision Medicine. Handbook of Biomarkers and Precision Medicine
121
127
.
Harald Enzmann, Norbert Benda, Ralf Meyer, Catharina Scholl, Julia Stingl & Karl Broich. 2019. Companion and Complementary Diagnostics. Companion and Complementary Diagnostics
319
333
.
Christina H. Liu, Pushpa Tandon & Luisa M. Russell. 2019. Nanotheranostics for Cancer Applications. Nanotheranostics for Cancer Applications
133
162
.
Marvin J. Fritzler, Laura Martinez-Prat, May Y. Choi & Michael Mahler. (2018) The Utilization of Autoantibodies in Approaches to Precision Health. Frontiers in Immunology 9.
Crossref
Crossref
Emily B. Ehlerding, Carolina A. Ferreira, Eduardo Aluicio-Sarduy, Dawei Jiang, Hye Jin Lee, Charles P. Theuer, Jonathan W. Engle & Weibo Cai. (2018)
86/90
Y-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model
. Molecular Pharmaceutics 15:7, pages 2606-2613.
Crossref
Crossref
Emily B. Ehlerding, Piotr Grodzinski, Weibo Cai & Christina H. Liu. (2018) Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics. ACS Nano 12:3, pages 2106-2121.
Crossref
Crossref
Bernadette V. Marquez-Nostra, Supum Lee, Richard Laforest, Laura Vitale, Xingyu Nie, Krzysztof Hyrc, Tibor Keler, Thomas Hawthorne, Jeremy Hoog, Shunqiang Li, Farrokh Dehdashti, Cynthia X. Ma & Suzanne E. Lapi. (2017) Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent. Oncotarget 8:61, pages 104303-104314.
Crossref
Crossref
Suzanne Jenkins, James C-H. Yang, Suresh S. Ramalingam, Karen Yu, Sabina Patel, Susie Weston, Rachel Hodge, Mireille Cantarini, Pasi A. Jänne, Tetsuya Mitsudomi & Glenwood D. Goss. (2017) Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non–Small Cell Lung Cancer. Journal of Thoracic Oncology 12:7, pages 1061-1070.
Crossref
Crossref
Tatjana Opacic, Vera Paefgen, Twan Lammers & Fabian Kiessling. (2016) Status and trends in the development of clinical diagnostic agents. WIREs Nanomedicine and Nanobiotechnology 9:4.
Crossref
Crossref
Alessandro Buriani, Stefano Fortinguerra & Maria Carrara. 2017. Toxicology of Herbal Products. Toxicology of Herbal Products
385
476
.
Natasa Bogavac-Stanojevic & Dragana Lakic. (2016) Biomarkers for Major Depressive Disorder: Economic Considerations. Drug Development Research 77:7, pages 374-378.
Crossref
Crossref
Irina I Agoulnik. (2016) Patient-Centric Healthcare of the Future from the Prospective of Biomedical Research and Technology. Journal of Analytical & Pharmaceutical Research 2:4.
Crossref
Crossref
Susannah L. Collins, Daniel F. Carr & Munir Pirmohamed. (2015) Advances in the Pharmacogenomics of Adverse Drug Reactions. Drug Safety 39:1, pages 15-27.
Crossref
Crossref